Reliability of the Neurophysiology of Pain Questionnaire in the Neck Pain the Cross-validation Study

October 31, 2022 updated by: Özden Laçin, Istanbul Arel University
The aim of this study is to study the validity and reliability of the Modified Pain Neurophysiology Questionnaire in patients with neck pain. After the ethics committee approval, women and men in Turkey will be invited to the research via online advertisements (researchers' facebook, instagram, twitter accounts). The scale will be translated from English to Turkish by two people who are fluent in Turkish and English. A single Turkish translation will be obtained with a common opinion from these two Turkish translations. In ten trial phases, a preliminary assessment will be conducted with 15 participants to test the intelligibility of the scale. If there are participants who think that there is a problem with the intelligibility of the scale, they will be asked to explain which items they have problems understanding and why. After individuals are informed with the online voluntary consent form, participants will be asked to complete the Modified Pain Neurophysiology questionnaire. Modified Pain Neurophysiology scale questions and questions in the data collection form will be prepared through the google surveys application and will be sent to the participants via Whatsapp, Facebook, Instagram and e-mail. Participants will fill out the survey forms online. In order to evaluate the validity of the Modified Pain Neurophysiology questionnaire, the pain subscale of the SF-36 scale, which has been validated in Turkish, will be used (McHorney, Ware, Lu, and Sherbourne, 1994), (Kocyigit et al., 1999). Scales after 15 days to assess test-retest reliability will be repeated.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey
      • Istanbul, Turkey
        • Recruiting
        • İSTANBUL

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Persons who meet the inclusion criteria and who volunteered to participate in the study

Description

Inclusion Criteria:

  • be between the ages of 18-65
  • Having neck pain complaints for the last 3 months
  • Adult individuals who agreed to participate in the study. Their mother tongue is Turkish.

Exclusion Criteria:

  • Not answering all the questions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain subscale of the SF-36 questionnaire
Time Frame: baseline
We will use only the pain subscale of the validated Turkish version of the SF-36 questionnaire
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul Arel University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Actual)

October 30, 2022

Study Completion (Anticipated)

May 1, 2023

Study Registration Dates

First Submitted

October 31, 2022

First Submitted That Met QC Criteria

October 31, 2022

First Posted (Actual)

November 7, 2022

Study Record Updates

Last Update Posted (Actual)

November 7, 2022

Last Update Submitted That Met QC Criteria

October 31, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NPQ Cross-validation

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe